Mode
Text Size
Log in / Sign up

Bipolar I Disorder

Part of Bipolar Disorder

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Bipolar I Disorder

42 trials tracked for Bipolar I Disorder: 26 in phase 3 or 4 and 11 with published results. The most-cited published study has 127 citations.

42Trials tracked
26Phase 3 & 4
0Recruiting
11With published results
Phase distribution
Phase 4 4 Phase 3 22 Phase 2 11 Phase 1 2 Other / NA 3
  1. Phase 3 Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients Completed · 127 cited
  2. Phase 3 Safety and Efficacy of Cariprazine for Bipolar I Disorder Completed · 119 cited
  3. Phase 3 Sensoril(Ashwaganhda)for Bipolar Disorder Completed · 114 cited
  4. Phase 3 Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder Completed · 36 cited
  5. Phase 4 Sequential Multiple Assignment Treatment for Bipolar Disorder Completed · 28 cited
  6. Phase 4 The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. Completed · 18 cited
Show 36 more trials
  1. Phase 3 Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder Completed · 15 cited
  2. Phase 3 A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder. Completed · 10 cited
  3. Phase 3 Staccato Loxapine in Agitated Patients With Bipolar Disorder Completed · 10 cited
  4. Phase 3 Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Completed · 9 cited
  5. Phase 3 Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 Completed · 6 cited
  6. Phase 4 A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients Completed
  7. Phase 4 Study in Adolescents With Schizophrenia or Bipolar Disorder Completed
  8. Phase 3 Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Completed
  9. Phase 3 This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Completed
  10. Phase 3 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder Completed
  11. Phase 3 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder Completed
  12. Phase 3 A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder. Completed
  13. Phase 3 A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features Completed
  14. Phase 3 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Completed
  15. Phase 3 Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed Completed
  16. Phase 3 A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Completed
  17. Phase 3 A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Completed
  18. Phase 3 Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder Completed
  19. Phase 3 Risperdal Consta for Bipolar Disorder Completed
  20. Phase 3 A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode Completed
  21. Phase 2 Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain Completed
  22. Phase 2 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder Completed
  23. Phase 2 Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents Completed
  24. Phase 2 Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders Completed
  25. Phase 2 A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode Completed
  26. Phase 2 Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder Completed
  27. Phase 2 Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder Completed
  28. Phase 2 Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System Completed
  29. Phase 2 A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder Completed
  30. Phase 2 Gabapentin for Bipolar & Cannabis Use Disorders Completed
  31. Phase 2 Treating Smokers With Mental Illness Completed
  32. Phase 1 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) Completed
  33. Phase 1 A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020) Completed
  34. N/A iTBS in Bipolar I Depression Completed
  35. N/A Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study Completed
  36. N/A A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion Completed

Showing the 42 most-cited and recently-updated of 42 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Bipolar Disorder

Related studies from across the Bipolar Disorder family.

Meta-analysis reveals shorter telomeres in bipolar disorder versus healthy control populations across large sample sizes
Psychiatry Meta-analysis
Meta-analysis reveals shorter telomeres in bipolar disorder versus healthy control populations across large sample sizes Meta-analysis links bipolar disorder to shorter telomeres in a very large group
This meta-analysis of 5,639 patients with bipolar disorder and 226,358 healthy controls found significantly shorter telomere lengths. The as…
A massive analysis of nearly 60,000 people found that those with bipolar disorder had shorter telomeres than healthy controls.
Bipolar disorder is associated with a 3.65-fold higher risk of Parkinson's disease in six cohort studies
Neurology Meta-analysis
Bipolar disorder is associated with a 3.65-fold higher risk of Parkinson's disease in six cohort studies People with bipolar disorder face higher risk of developing Parkinson's disease based on recent analysis
This meta-analysis of six cohort studies evaluated the incidence of Parkinson's disease in individuals with bipolar disorder. The pooled ana…
A review of six studies found people with bipolar disorder have a much higher chance of getting Parkinson's disease. However, experts say we…
Cocaine use disorder prevalence in bipolar disorder is 10.94 percent with worse clinical outcomes
Psychiatry Meta-analysis
Cocaine use disorder prevalence in bipolar disorder is 10.94 percent with worse clinical outcomes One in ten people with bipolar disorder also struggles with cocaine use
This systematic review and meta-analysis of 6,150,881 individuals with bipolar disorder found a pooled overall prevalence of cocaine use dis…
A large review found that 11 percent of people with bipolar disorder also have cocaine use disorder, a number that jumps to 46 percent in sp…
GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates
Psychiatry Meta-analysis
GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates New drugs help people with severe mental illness lose weight safely
This systematic review and meta-analysis evaluated glucagon-like peptide-1 receptor agonists in individuals with severe mental illness who h…
New weight loss drugs work well and stay safe for people with severe mental illness who struggle with obesity and high blood sugar.
Diffusion tensor imaging shows lower fractional anisotropy in bipolar disorder white matter tracts
Psychiatry Meta-analysis
Diffusion tensor imaging shows lower fractional anisotropy in bipolar disorder white matter tracts Bipolar Brain Wiring Shows Clear Damage in Key Emotional Pathways
This systematic review and meta-analysis of diffusion tensor imaging studies compared 5,372 individuals with bipolar disorder to 6,240 healt…
Brain scans reveal consistent white matter damage in bipolar disorder, especially in tracts that regulate emotion and connect brain hemisphe…
Meta-analysis finds decreased GDNF levels in bipolar disorder but high heterogeneity limits conclusions
Psychiatry Meta-analysis
Meta-analysis finds decreased GDNF levels in bipolar disorder but high heterogeneity limits conclusions Brain chemical levels differ in bipolar disorder compared to healthy people
This meta-analysis of 825 patients with bipolar disorder (BD) and 885 healthy controls found significantly lower circulating GDNF levels in …
A large review found lower levels of a specific brain chemical in people with bipolar disorder. This difference was clear even when comparin…
Meta-analysis reviews psychosis prevalence in bipolar disorder patients across 285 studies
Psychiatry Meta-analysis
Meta-analysis reviews psychosis prevalence in bipolar disorder patients across 285 studies Psychosis common in bipolar disorder, review finds
This meta-analysis reviews data from 285 studies regarding the prevalence of psychosis and psychotic symptoms in patients with bipolar disor…
Nearly half of people with bipolar disorder experience psychosis, and 8% also have schizophrenia, a review of 285 studies finds.
Narrative review explores microbiome mechanisms as a promising adjunctive avenue for managing depression, anxiety, bipolar disorder, and schizophrenia
Psychiatry Sys. Review
Narrative review explores microbiome mechanisms as a promising adjunctive avenue for managing depression, anxiety, bipolar disorder, and schizophrenia Gut Bacteria Can Change Your Mood
This narrative review examines how microbiome-driven modulation of neurotransmitters, microbial metabolites, immune activation, and vagal ne…
What if the bacteria in your gut could be quietly shaping how you feel every day — and fixing them could ease anxiety or depression?
Observational study identifies sensory perception differences in schizophrenia and first-episode psychosis
Psychiatry
Observational study identifies sensory perception differences in schizophrenia and first-episode psychosis Simple tests reveal unique sensory signs for early psychosis types
This observational study investigated psychophysical differences in pictorial size perception and auditory discomfort among patients with sc…
New low-cost tests can spot unique sensory changes that help doctors tell schizophrenia apart from bipolar disorder in early psychosis cases…
Parental severe mental illness associated with reduced offspring cognitive and academic performance in large meta-analysis
Psychiatry Meta-analysis
Parental severe mental illness associated with reduced offspring cognitive and academic performance in large meta-analysis Children of parents with mental illness face real cognitive hurdles now
This meta-analysis examined 1,586,339 offspring of parents with severe mental illnesses, including schizophrenia, bipolar disorder, and majo…
New research shows kids of parents with severe mental illness struggle with memory and thinking skills, but early help can make a big differ…
Narrative review examines multidisciplinary strategies for metabolic syndrome in bipolar disorder
Psychiatry Sys. Review
Narrative review examines multidisciplinary strategies for metabolic syndrome in bipolar disorder Half of Bipolar Patients Face Hidden Heart Risks
This narrative review explores multidisciplinary monitoring and treatment strategies, including lifestyle and pharmacological approaches, fo…
Imagine living with bipolar disorder. You manage your mood swings with medication and therapy.
Blood biomarker variance in UK Biobank influenced by technical, demographic, and behavioral factors
Psychiatry Cohort
Blood biomarker variance in UK Biobank influenced by technical, demographic, and behavioral factors Why Blood Tests Fail to Predict Mental Health
This UK Biobank cohort study examined how technical, demographic, behavioral, and temporal factors influence 29 blood biomarkers.
Many doctors rely on blood work to check your physical health.